Go Pro

Arbutus Biopharma (ABUS) Institutional Ownership

Arbutus Biopharma logo
$4.36 +0.02 (+0.46%)
Closing price 04:00 PM Eastern
Extended Trading
$4.37 +0.01 (+0.21%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Arbutus Biopharma (NASDAQ:ABUS)

Current
Institutional Ownership
Percentage
43.79%
Number of
Institutional Buyers
(last 12 months)
82
Total
Institutional Inflows
(last 12 months)
$98.04M
Number of
Institutional Sellers
(last 12 months)
46
Total
Institutional Outflows
(last 12 months)
$40.56M
Get ABUS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arbutus Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ABUS Institutional Buying and Selling by Quarter

Arbutus Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/3/2026Walleye Trading LLC14,000$67K0.0%N/A0.007%
5/28/2026Avidity Partners Management LP125,000$562K0.1%N/A0.063%
5/19/2026Front Row Advisors LLC110,500$497K0.2%+952.4%0.056%
5/19/2026Bank of America Corp DE1,683,628$7.58M0.0%-8.1%0.852%
5/18/2026ADAR1 Capital Management LLC3,133,175$14.10M0.8%-42.1%1.586%
5/18/2026Rubric Capital Management LP6,626,389$29.82M0.3%+320.6%3.354%
5/16/2026The Manufacturers Life Insurance Company 42,429$191K0.0%-10.6%0.021%
5/16/2026Quantinno Capital Management LP48,715$219K0.0%-10.9%0.025%
5/15/2026Rangeley Capital LLC500,000$2.25M2.1%-40.5%0.253%
5/14/2026Inceptionr LLC32,580$147K0.0%+14.6%0.017%
5/5/2026Bank of New York Mellon Corp379,373$1.71M0.0%-2.2%0.193%
5/4/2026Principal Financial Group Inc.10,977$49K0.0%N/A0.006%
4/28/2026 Abel Hall LLC20,073$90K0.0%-34.8%0.010%
4/16/2026SG Americas Securities LLC79,033$356K0.0%+89.8%0.040%
2/19/2026Invesco Ltd.247,254$1.19M0.0%+17.9%0.129%
2/18/2026Mercer Global Advisors Inc. ADV45,120$217K0.0%+15.8%0.023%
2/18/2026Virtus Investment Advisers LLC56,483$272K0.1%+77.7%0.029%
2/18/2026Wellington Management Group LLP474,361$2.28M0.0%-7.7%0.247%
2/18/2026Saba Capital Management L.P.347,885$1.67M0.0%-48.7%0.181%
2/18/2026Oxford Asset Management LLP21,632$104K0.0%N/A0.011%
2/18/2026Man Group plc120,821$581K0.0%+52.2%0.063%
2/18/2026Irenic Capital Management LP59,853$288K0.0%N/A0.031%
2/18/2026Balyasny Asset Management L.P.141,646$681K0.0%+31.6%0.074%
2/17/2026ADAR1 Capital Management LLC5,415,109$26.05M1.9%+86.5%2.816%
2/17/2026 Abel Hall LLC30,779$148K0.0%N/A0.016%
2/17/2026Lazard Asset Management LLC67,840$326K0.0%N/A0.035%
2/17/2026Amundi11,878$57K0.0%N/A0.006%
2/17/2026Price T Rowe Associates Inc. MD89,216$430K0.0%+7.5%0.046%
2/17/2026Osaic Holdings Inc.1,348,224$6.49M0.0%+0.7%0.701%
2/17/2026Adage Capital Partners GP L.L.C.4,339,941$20.88M0.0%-13.5%2.257%
2/17/2026California State Teachers Retirement System144,110$693K0.0%+9.6%0.075%
2/17/2026State of Wisconsin Investment Board92,769$446K0.0%+621.2%0.048%
2/17/2026ExodusPoint Capital Management LP30,503$147K0.0%-63.0%0.016%
2/17/2026Royal Bank of Canada65,687$316K0.0%-72.3%0.034%
2/16/2026Squarepoint Ops LLC28,775$138K0.0%-57.4%0.015%
2/16/2026Verition Fund Management LLC20,000$96K0.0%N/A0.010%
2/16/2026Barclays PLC356,684$1.72M0.0%+25.4%0.185%
2/13/2026The Manufacturers Life Insurance Company 47,459$228K0.0%-12.4%0.025%
2/13/2026Hudson Bay Capital Management LP675,000$3.25M0.0%-15.6%0.351%
2/13/2026Morgan Stanley26,702,776$128.44M0.0%+9.2%13.885%
Buy this stock tomorrow (Ad)

Marc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership with Nvidia - one he believes positions it ahead of Tesla in the autonomous vehicle race. With a market-moving announcement expected on July 31st, Chaikin is urging investors to swap overpriced AI stocks for this under-the-radar name before markets open. He's also releasing a free Hotlist and Hitlist of buy and sell ideas for the second half of 2026.tc pixel

Get the ticker symbol and full details at no charge today
2/13/2026Rafferty Asset Management LLC117,032$563K0.0%+120.8%0.061%
2/13/2026Charles Schwab Investment Management Inc.1,562,265$7.51M0.0%+22.5%0.812%
2/13/2026State Street Corp5,908,211$28.42M0.0%+44.2%3.072%
2/13/2026Dynamic Technology Lab Private Ltd25,779$124K0.0%N/A0.013%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC890,898$4.29M0.0%N/A0.463%
2/13/2026Wells Fargo & Company MN167,021$803K0.0%+75.0%0.087%
2/12/2026MetLife Investment Management LLC73,236$352K0.0%-16.6%0.038%
2/12/2026Cibc World Markets Corp10,015$48K0.0%N/A0.005%
2/12/2026EntryPoint Capital LLC75,607$364K0.1%+161.9%0.039%
2/12/2026Ensign Peak Advisors Inc27,600$133K0.0%-38.7%0.014%
2/12/2026 AlphaCentric Advisors LLC47,925$231K0.2%N/A0.025%
2/12/2026Campbell & CO Investment Adviser LLC113,113$544K0.0%+54.3%0.059%
2/12/2026Swiss National Bank283,400$1.36M0.0%+2.6%0.147%
2/11/2026Inceptionr LLC28,418$137K0.0%N/A0.015%
2/11/2026 T3 Companies LLC34,000$164K0.2%N/A0.018%
2/11/2026Deutsche Bank AG140,198$674K0.0%+6.4%0.073%
2/11/2026Los Angeles Capital Management LLC46,520$225K0.0%N/A0.024%
2/11/2026Two Seas Capital LP12,589,158$60.55M1.2%+14.5%6.546%
2/11/2026State of Wyoming15,421$74K0.0%N/A0.008%
2/10/2026CIBC Asset Management Inc14,382$69K0.0%N/A0.007%
2/10/2026Goldman Sachs Group Inc.738,580$3.55M0.0%-66.0%0.384%
2/10/2026Intech Investment Management LLC70,563$339K0.0%+48.6%0.037%
2/9/2026Geode Capital Management LLC3,677,307$17.69M0.0%+0.3%1.912%
2/6/2026ProShare Advisors LLC36,161$174K0.0%+10.5%0.019%
2/3/2026Mitsubishi UFJ Asset Management Co. Ltd.54,066$258K0.0%-26.6%0.028%
2/3/2026 SBI Securities Co. Ltd.29,625$142K0.0%-31.0%0.015%
1/28/2026Arizona State Retirement System39,962$192K0.0%-5.7%0.021%
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank128,315$617K0.0%+27.9%0.067%
1/26/2026 PFG Investments LLC11,000$53K0.0%-18.5%0.006%
1/20/2026 Wealth Management Associates Inc.127,870$615K0.2%+13.3%0.066%
1/9/2026SG Americas Securities LLC41,638$200K0.0%+78.1%0.022%
1/1/2026JPMorgan Chase & Co.98,229$446K0.0%+14.1%0.051%
12/15/2025Hudson Bay Capital Management LP800,000$3.63M0.0%-17.1%0.416%
11/21/2025CIBC Bancorp USA Inc.16,138$73K0.0%N/A0.008%
11/17/2025Woodline Partners LP2,165,602$9.83M0.0%-13.3%1.130%
11/17/2025Two Seas Capital LP10,991,261$49.90M0.8%+5.2%5.734%
11/17/2025Voleon Capital Management LP10,403$47K0.0%N/A0.005%
11/17/2025Sherbrooke Park Advisers LLC37,073$168K0.1%+71.4%0.019%
11/17/2025Qube Research & Technologies Ltd215,041$976K0.0%-41.6%0.112%
11/17/2025Mercer Global Advisors Inc. ADV38,959$177K0.0%+9.2%0.020%
11/17/2025Millennium Management LLC528,340$2.40M0.0%+5.8%0.276%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.73,806$335K0.0%-15.5%0.039%
11/17/2025Jain Global LLC26,000$118K0.0%N/A0.014%
11/17/2025Foursixthree Capital LP1,978,975$8.99M2.5%-22.6%1.032%
11/17/2025Bank of America Corp DE1,450,822$6.59M0.0%+21.1%0.757%
11/17/2025Alliancebernstein L.P.143,870$653K0.0%+19.7%0.075%
11/14/2025Man Group plc79,374$360K0.0%+103.5%0.041%
11/14/2025ADAR1 Capital Management LLC2,903,226$13.18M1.2%+2.7%1.514%
11/14/2025Brooklyn Investment Group14,163$64K0.0%+3,485.6%0.007%
11/14/2025Squarepoint Ops LLC67,611$307K0.0%+184.0%0.035%
Buy this stock today (Ad)

Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.tc pixel

Get the name, ticker, and full Hotlist before markets open
11/14/2025Quinn Opportunity Partners LLC514,513$2.34M0.2%+10.8%0.268%
11/13/2025Kennedy Capital Management LLC505,099$2.29M0.1%+12.4%0.263%
11/13/2025Arrowstreet Capital Limited Partnership159,118$722K0.0%N/A0.083%
11/13/2025UBS Group AG774,594$3.52M0.0%+307.2%0.404%
11/13/2025BNP Paribas Financial Markets89,899$408K0.0%+60.7%0.047%
11/13/2025Russell Investments Group Ltd.22,739$103K0.0%+186.0%0.012%
11/12/2025Barclays PLC284,330$1.29M0.0%-30.1%0.148%
11/12/2025Rafferty Asset Management LLC53,008$241K0.0%-40.1%0.028%
11/12/2025Western Standard LLC507,853$2.31M0.7%N/A0.265%
11/12/2025Intech Investment Management LLC47,489$216K0.0%-37.4%0.025%


ABUS Institutional Ownership - Frequently Asked Questions

During the previous two years, 137 institutional investors and hedge funds held shares of Arbutus Biopharma. The most heavily invested institutionals were Morgan Stanley ($128.44M), Two Seas Capital LP ($60.55M), Whitefort Capital Management LP ($43.30M), Vanguard Group Inc. ($40.82M), Rubric Capital Management LP ($29.82M), State Street Corp ($28.42M), and Adage Capital Partners GP L.L.C. ($20.88M).Learn more on Arbutus Biopharma's institutional investors.

43.79% of Arbutus Biopharma's stock is owned by institutional investors. Learn more on ABUS's institutional investor holdings.

Of the 117 institutional investors that purchased Arbutus Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Rubric Capital Management LP ($6.73M), Two Seas Capital LP ($4.56M), State Street Corp ($3.28M), Goldman Sachs Group Inc. ($3.09M), ADAR1 Capital Management LLC ($2.91M), Morgan Stanley ($2.25M), and Woodline Partners LP ($1.99M).

Institutional investors have bought a total of 22,209,995 shares in the last 24 months. This purchase volume represents approximately $98.04M in transactions.

Of the 46 institutional investors that sold Arbutus Biopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: ADAR1 Capital Management LLC ($2.28M), Goldman Sachs Group Inc. ($1.43M), Hudson Bay Capital Management LP ($851.80K), Rangeley Capital LLC ($824K), Adage Capital Partners GP L.L.C. ($675K), Foursixthree Capital LP ($578.39K), and JPMorgan Chase & Co. ($452.55K).

Institutional investors have sold a total of 9,378,598 shares in the last 24 months. This volume of shares sold represents approximately $40.56M in transactions.



This page (NASDAQ:ABUS) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners